Novel Repositioning Therapy for Drug-Resistant Glioblastoma: <i>In</i> <i>vivo</i> Validation Study of Clindamycin Treatment Targeting the mTOR Pathway and Combination Therapy with TemozolomideTakeyoshi Eda, Manabu Natsumeda|Preprints.org|2021Cited by 1
SGLT2 inhibition suppresses glioblastoma cell proliferation via AMPK activation and mTOR-dependent reduction of protein synthesis under glucose starvationTakeyoshi Eda, Manabu Natsumeda|Research Square|2026Cited by 0